Innoviva (INVA) Current Assets (2010 - 2026)

Innoviva (INVA) reported Current Assets of $772.6 million for Q1 2026, up 32.75% on a YoY basis from $582.0 million in Q1 2025, and up 6.2% quarter-over-quarter from $727.5 million in Q4 2025.

Innoviva (INVA) Current Assets (2010 - 2026) Analysis & Trends

Innoviva has reported Current Assets for 17 years, with the latest figure at $772.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Current Assets rose 32.75% year-over-year to $772.6 million; the trailing twelve-month figure through Mar 2026 stood at $772.6 million (up 32.75% YoY), and the FY2025 full-year result was $727.5 million, up 31.25% from the prior year.
  • Current Assets for Q1 2026 stood at $772.6 million, up from $727.5 million in the prior quarter.
  • The five-year high for Current Assets was $772.6 million in Q1 2026, with the low at $16.9 million in Q3 2025.
  • Historically, Current Assets has averaged $364.3 million across 5 years, with a median of $344.2 million in 2023.
  • Annual changes were most pronounced in 2022 — Current Assets soared 170.02% — and 2024, when it plunged 38.8%.
  • Innoviva's Current Assets stood at $443.5 million in 2022, then retreated by 22.39% to $344.2 million in 2023, then soared by 61.03% to $554.3 million in 2024, then surged by 31.25% to $727.5 million in 2025, then rose by 6.2% to $772.6 million in 2026.
  • The last three Current Assets figures came in at $772.6 million (Q1 2026), $727.5 million (Q4 2025), and $16.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 37.31 Mn
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 521.86 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 10.37 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 1.25 Bn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 3.59 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 7.63 Mn
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 11.73 Bn
9 Abivax 90.15 Bn 90.15 Bn - 600.85 Mn
10 Innoviva 1.69 Bn 1.08 Bn 75.83 Mn 772.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 772.62 Mn
Dec 31, 2025 727.52 Mn
Sep 30, 2025 16.93 Mn
Jun 30, 2025 651.78 Mn
Mar 31, 2025 582.02 Mn
Dec 31, 2024 554.31 Mn
Sep 30, 2024 22.39 Mn
Jun 30, 2024 358.28 Mn
Mar 31, 2024 311.34 Mn
Dec 31, 2023 344.22 Mn
Sep 30, 2023 36.59 Mn
Jun 30, 2023 323.54 Mn
Mar 31, 2023 296.45 Mn
Dec 31, 2022 443.51 Mn
Sep 30, 2022 33.25 Mn
Jun 30, 2022 400.33 Mn
Mar 31, 2022 317.82 Mn
Dec 31, 2021 313.67 Mn
Sep 30, 2021 49.75 Mn
Jun 30, 2021 148.26 Mn